Twin Tree Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-146,300
Closed -$15.4M 1298
2022
Q2
$15.4M Sell
146,300
-9,300
-6% -$1.19M 0.02% 504
2022
Q1
$26.8M Buy
+155,600
New +$23.2M 0.04% 378
2021
Q1
Sell
-5,400
Closed -$1.58M 1324
2020
Q4
$1.58M Buy
+5,400
New +$1.38M 0.01% 902
2020
Q3
Sell
-11,500
Closed -$2.28M 1201
2020
Q2
$2.28M Buy
+11,500
New +$2.14M 0.01% 852

Other funds holding AMED

Twin Tree Management's AMED Position: Q3 2022 in Review

Twin Tree Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 106,236 shares — an estimated $11.2M sold.

Twin Tree Management first reported a position in AMED in Q2 2020 and held it in 3 quarters. The position peaked at $11.2M in Q2 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Twin Tree Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Twin Tree Management sold 106,236 Amedisys shares in Q3 2022, an estimated $11.2M.
  • Twin Tree Management first reported a position in Amedisys in Q2 2020 and held it in 3 quarters.
  • Twin Tree Management's Amedisys position peaked at $11.2M in Q2 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Twin Tree Management's 13F filing for Q3 2022, filed 10 Nov 2022.